Pages that link to "Q28343035"
Jump to navigation
Jump to search
The following pages link to Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. tuberculosis and their penetration into mouse peritoneal macrophages (Q28343035):
Displaying 27 items.
- Evaluation of rifapentine in long-term treatment regimens for tuberculosis in mice (Q28343604) (← links)
- Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazid-rifampin therapy in a mouse tuberculosis model (Q28344872) (← links)
- Evaluation of once-weekly therapy for tuberculosis using isoniazid plus rifamycins in the mouse aerosol infection model (Q28369170) (← links)
- Development of rifapentine susceptibility tests for Mycobacterium tuberculosis (Q28369453) (← links)
- Comparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophages (Q28378747) (← links)
- Bacteriostatic and bactericidal activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium in human macrophages (Q28379003) (← links)
- Low-dose aerosol infection model for testing drugs for efficacy against Mycobacterium tuberculosis (Q28379615) (← links)
- Pharmacokinetic factors in the modern drug treatment of tuberculosis. (Q30322975) (← links)
- Rifapentine: its role in the treatment of tuberculosis (Q33779876) (← links)
- Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. (Q33962909) (← links)
- Single-dose intrapulmonary pharmacokinetics of rifapentine in normal subjects (Q33979162) (← links)
- Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials (Q34296734) (← links)
- Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis (Q35102656) (← links)
- Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium (Q35822975) (← links)
- Comparison of biological and chemical assays for the quantitation of rifapentine in human plasma (Q36861330) (← links)
- Rifamycins--obstacles and opportunities (Q37710834) (← links)
- Bactericidal activity of the diarylquinoline TMC207 against Mycobacterium tuberculosis outside and within cells (Q39664217) (← links)
- Reporter gene technology to assess activity of antimycobacterial agents in macrophages (Q39782337) (← links)
- Flow-regulatory function of upper airway in health and disease: a unified pathogenetic view of sleep-disordered breathing (Q40808340) (← links)
- Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice (Q42286897) (← links)
- Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex (Q43507916) (← links)
- Role of Isoniazid in Once-Weekly Rifapentine Treatment of Pulmonary Tuberculosis (Q44435073) (← links)
- Effect of sex and AIDS status on the plasma and intrapulmonary pharmacokinetics of rifampicin (Q44845821) (← links)
- Mycobacterium microti--pulmonary tuberculosis in an immunocompetent patient. (Q45948700) (← links)
- The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis (Q46417486) (← links)
- Upper airway dilating muscle hyperactivity during non-rapid eye movement sleep in English bulldogs (Q48866819) (← links)
- Comparative in vitro activities of rifamycin analogues against rifampin-sensitive and rifampin-resistant Mycobacterium tuberculosis (Q81605893) (← links)